{
    "Trade/Device Name(s)": [
        "Xpert FII & FV",
        "Xpert Factor II & Factor V"
    ],
    "Submitter Information": "Cepheid",
    "510(k) Number": "K250218",
    "Predicate Device Reference 510(k) Number(s)": [
        "K223046"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NPR",
        "NPQ",
        "OOI"
    ],
    "Summary Letter Date": "February 21, 2025",
    "Summary Letter Received Date": "January 24, 2025",
    "Submission Date": "January 24, 2025",
    "Regulation Number(s)": [
        "21 CFR 864.7280"
    ],
    "Regulation Name(s)": [
        "Factor V Leiden DNA Mutation Detection Systems"
    ],
    "Analyte Class(es)": [
        "genetic molecular",
        "hematology"
    ],
    "Analyte(s)": [
        "Factor II (G20210A)",
        "Factor V Leiden (G1691A)"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [
        "Sodium citrate tube",
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "GeneXpert Dx System",
        "GeneXpert Infinity System",
        "GeneXpert System with Touchscreen"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Automated nucleic acid amplification",
        "Fluorogenic target-specific hybridization"
    ],
    "Methodologies": [
        "Genotyping",
        "PCR",
        "Nucleic acid amplification"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for Xpert FII & FV automated real-time PCR genotyping assay for Factor II and Factor V mutations performed on GeneXpert Instrument Systems",
    "Indications for Use Summary": "Qualitative in vitro genotyping test for detection of Factor II (G20210A) and Factor V Leiden (G1691A) mutations from sodium citrate or EDTA anticoagulated whole blood as an aid in diagnosis of suspected thrombophilia, performed on GeneXpert Instrument Systems",
    "fda_folder": "Hematology"
}